Tatiana Hernandez-Guerrero

12PUBLICATIONS
99CO-AUTHORS
Predictive and prognostic markersMolecular targetsToxicology (incl. clinical toxicology)Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 20, 2026
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.

|Oct 24, 2025
Prolonged survival in a patient with pbrm1 mutated metastatic cholangiocarcinoma receiving tazemetostat.

Manuel Pedregal, Esther Cabañas Morafraile, Alberto Garrido

|Jul 25, 2025
Derivation and External Validation of Objective Performance Status Among Patients With Metastatic Cancer.

Eva Ruiz, Christopher R Manz, Anthony Girard

|May 13, 2025
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer.

Harveer Dev, Mark Linch, Krishna Narahari

|Apr 26, 2024
Pharmacokinetics and Safety of Lurbinectedin Administrated with Itraconazole in Cancer Patients: A Drug-Drug Interaction Study.

Irene Moreno, Tatiana Hernández, Emiliano Calvo

|Feb 24, 2024
Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug-Drug Interaction Study.

Irene Moreno, Tatiana Hernández, Emiliano Calvo

Pageof 2

Frequent Collaborators

8 joint publications

Victor Moreno

5 joint publications

Emiliano Calvo

2 joint publications

Irene Moreno

2 joint publications

Daniel Morillo